Malta - engelska - Medicines Authority

atnahs pharma netherlands b.v. copenhagen towers Ørestads boulevard 108, 5.tv dk-2300 københavn s , denmark - lisinopril dihydrate - tablet - lisinopril dihydrate 10 mg - agents acting on the renin-angiotensin system

Malta - engelska - Medicines Authority

atnahs pharma netherlands b.v. copenhagen towers Ørestads boulevard 108, 5.tv dk-2300 københavn s , denmark - lisinopril dihydrate - tablet - lisinopril dihydrate 20 mg - agents acting on the renin-angiotensin system

USA - engelska - NLM (National Library of Medicine)

atnahs pharma us limited - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - carefully consider the potential benefits and risks of ketorolac tromethamine tablets usp and other treatment options before deciding to use ketorolac tromethamine tablets usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. ketorolac tromethamine tablets usp are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with iv or im dosing of ketorolac tromethamine and ketorolac tromethamine tablets usp are to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine tablets usp and ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and administration, and adverse reactions ). patients should b

Australien - engelska - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - tetracosactide, quantity: 1 mg/ml - injection, modified release - excipient ingredients: hydrochloric acid; water for injections; dibasic sodium phosphate dihydrate; sodium chloride; zinc chloride; sodium hydroxide; benzyl alcohol - neurological diseases: acute exacerbations in patients suffering from multiple sclerosis. hypsarrhythmia, and or infantile spasms

Australien - engelska - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - tetracosactide, quantity: 0.25 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; acetic acid; sodium acetate - indications as at 12 august 1999: as a diagnostic aid in the assessment of suspected adrenocortical hypofunction.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

clinect nz pty limited - cladribine 1 mg/ml - solution for infusion - 1 mg/ml - active: cladribine 1 mg/ml excipient: sodium chloride water for injection - leustatin is indicated in the treatment of patients with hairy cell leukaemia (hcl).

Irland - engelska - HPRA (Health Products Regulatory Authority)

atnahs pharma uk limited - olsalazine sodium - capsule - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine

Irland - engelska - HPRA (Health Products Regulatory Authority)

atnahs pharma uk limited - olsalazine sodium - tablet - 500 milligram(s) - aminosalicylic acid and similar agents; olsalazine

Singapore - engelska - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - ibandronic acid ( as monosodium monohydrate 56.25mg) - tablet, film coated - 50mg - ibandronic acid ( as monosodium monohydrate 56.25mg) 50mg

Singapore - engelska - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - ibandronic acid (ibandronate form) - tablet, film coated - 168.75 mg - ibandronic acid (ibandronate form) 168.75 mg